glp-1 and antidepressants Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in bipolar disorder: a narrative review of preclinical clinical evidence The Impact of GLP-1 Receptor
Description
Two or three flags = High Risk
You have Type 2 diabetes
Higher drug levels mean stronger insulin secretion in response to meals, which could theoretically cause hypoglycemia
When insulin does not work properly, glucose builds up in the blood
Combination of fenofibrate with non-statin drug regimens
Ko and Y
